165 related articles for article (PubMed ID: 11689146)
1. Chromosome 9 and 17 aberrations and p53 gene deletion detected by fluorescence in situ hybridization in renal-cell carcinoma.
Yoshioka K; Nakamura S
Mol Urol; 2001; 5(1):11-7. PubMed ID: 11689146
[TBL] [Abstract][Full Text] [Related]
2. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue.
Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P
Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914
[TBL] [Abstract][Full Text] [Related]
5. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma.
Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O
Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022
[TBL] [Abstract][Full Text] [Related]
6. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal findings and p53-mutation analysis in chromophilic renal-cell carcinomas.
Dijkhuizen T; Van den Berg E; Van den Berg A; Störkel S; De Jong B; Seitz G; Henn W
Int J Cancer; 1996 Sep; 68(1):47-50. PubMed ID: 8895539
[TBL] [Abstract][Full Text] [Related]
8. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
10. Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization.
Receveur AO; Couturier J; Molinié V; Vieillefond A; Desangles F; Guillaud-Bataille M; Danglot G; Coullin P; Bernheim A
Cancer Genet Cytogenet; 2005 Apr; 158(2):110-8. PubMed ID: 15796957
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
12. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.
Corless CL; Aburatani H; Fletcher JA; Housman DE; Amin MB; Weinberg DS
Diagn Mol Pathol; 1996 Mar; 5(1):53-64. PubMed ID: 8919546
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
[TBL] [Abstract][Full Text] [Related]
14. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
Siebert R; Jacobi C; Matthiesen P; Zühlke-Jenisch R; Potratz C; Zhang Y; Stöckle M; Klöppel G; Grote W; Schlegelberger B
J Urol; 1998 Aug; 160(2):534-9. PubMed ID: 9679924
[TBL] [Abstract][Full Text] [Related]
15. Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
Sanjmyatav J; Junker K; Matthes S; Muehr M; Sava D; Sternal M; Wessendorf S; Kreuz M; Gajda M; Wunderlich H; Schwaenen C
J Urol; 2011 Nov; 186(5):2078-83. PubMed ID: 21944119
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis of renal cell carcinoma and detection of numerical chromosome aberration].
Uchida K; Akaza H; Nemoto R; Nakamura Y
Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():313-9. PubMed ID: 9263522
[TBL] [Abstract][Full Text] [Related]
17. Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma.
Massari F; Ciccarese C; Bria E; Porta C; La Russa F; Knuutila S; Artibani W; Porcaro AB; Bimbatti D; Modena A; Sava T; Tortora G; Cheng L; Eccher A; Cima L; Pedron S; Ghimenton C; Martignoni G; Brunelli M
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):39-43. PubMed ID: 26509904
[TBL] [Abstract][Full Text] [Related]
18. Biphasic alveolosquamoid renal carcinoma: a histomorphological, immunohistochemical, molecular genetic, and ultrastructural study of a distinctive morphologic variant of renal cell carcinoma.
Petersson F; Bulimbasic S; Hes O; Slavik P; Martínek P; Michal M; Gomolčáková B; Hora M; Damjanov I
Ann Diagn Pathol; 2012 Dec; 16(6):459-69. PubMed ID: 23036259
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data.
Junker K; Moravek P; Podhola M; Weirich G; Hindermann W; Janitzky V; Schubert J
Int J Oncol; 2000 Nov; 17(5):903-8. PubMed ID: 11029490
[TBL] [Abstract][Full Text] [Related]
20. High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.
Kouba EJ; Eble JN; Simper N; Grignon DJ; Wang M; Zhang S; Wang L; Martignoni G; Williamson SR; Brunelli M; Luchini C; Calió A; Cheng L
Mod Pathol; 2016 Nov; 29(11):1347-1357. PubMed ID: 27469331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
